This study is testing whether a new drug called PRI-002 is safe and can help people with early-stage Alzheimer's disease. The drug is designed to break apart harmful clumps of protein in the brain that are thought to cause memory and thinking problems. About 304 people with mild …
Phase: PHASE2 • Sponsor: PRInnovation GmbH • Aim: Disease control
Last updated Mar 13, 2026 15:05 UTC